Essential Partners’s Elevation Oncology ELEV Stock Holding History

Essential Partners’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24	Closed	-$9	–	2705
2025 Q2	$9	Buy	+24	New	+$8	﹤0.01%	2253

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Essential Partners's ELEV Position: Q3 2025 in Review

Essential Partners sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 24 shares — an estimated $9 sold.

Essential Partners first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $9 in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Essential Partners reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Essential Partners sold 24 Elevation Oncology shares in Q3 2025, an estimated $9.
Essential Partners first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Essential Partners's Elevation Oncology position peaked at $9 in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.